On January 12, 2026, an update emerged for a clinical trial investigating pain levels associated with traditional versus ultrasound-guided intrauterine system (IUS) insertion. Sponsored by University Hospital, Ghent, and Imelda Hospital, Bonheiden, the study is currently in its preparatory phase. Healthcare providers, researchers, and regulatory professionals monitoring medical device performance should take interest in this research.
What is this trial about?
This clinical trial aims to compare pain levels experienced by patients undergoing traditional versus ultrasound-guided IUS insertion procedures. The primary intervention involves the placement of an intrauterine system, a long-term contraceptive device. The trial is supported by two prominent institutions: University Hospital, Ghent, and Imelda Hospital, Bonheiden. Although recruitment has not yet begun, the study’s design reflects growing interest in minimizing procedural discomfort and improving patient care through advanced techniques.
Why is this research significant?
The insertion of intrauterine systems is a widely practiced medical procedure with known instances of pain reported by patients. This trial attempts to shed light on whether the use of ultrasound guidance can mitigate discomfort compared to traditional insertion methods. With the increasing emphasis on patient-centered care, identifying ways to enhance procedural experiences is critical for both clinicians and device manufacturers.
The results of this study may influence best practices in device management and clinical procedures, and could impact regulatory standards concerning the performance and patient safety considerations of intrauterine systems. Healthcare providers and researchers involved in gynecological practices or medical device design may find the outcomes particularly actionable.
What are the expected outcomes?
The trial’s findings are expected to provide evidence aligning pain management strategies with patient needs. By exploring the efficacy of ultrasound guidance during device placement, the study could establish a foundation for updating clinical guidelines and improving the accessibility of intrauterine devices. Indirectly, it may also assist manufacturers by highlighting potential areas for device innovation or enhancing procedural training programs for clinicians.
Importantly, regulatory teams may use the results to assess compliance with the Medical Device Regulation (MDR) Annex XIV, which emphasizes device safety, performance, and risk management. The insights gathered could potentially strengthen the evidence base for performance claims related to intrauterine systems.
Frequently Asked Questions
- What is the current status of the trial?
The study is not yet recruiting participants as of January 12, 2026. - Who is sponsoring this research?
The research is co-sponsored by University Hospital, Ghent, and Imelda Hospital, Bonheiden. - What is the primary procedure being studied?
The trial focuses on the insertion of an intrauterine system, comparing traditional and ultrasound-guided methods. - How could this trial benefit patients?
It seeks to identify methods to minimize pain, potentially improving patient outcomes and experiences during IUS insertion.
Conclusion
This clinical trial represents a step forward in understanding and improving patient outcomes during intrauterine device insertion. Its focus on pain reduction through ultrasound-guided techniques aligns with broader efforts to ensure better clinical and regulatory outcomes. Stakeholders in healthcare and medical device industries are encouraged to follow developments closely for actionable findings.
Disclaimer
This content is intended for informational purposes and should not be considered legal or clinical advice. It is designed for professionals in clinical, regulatory, and associated sectors.
Announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07315646?term=medical+device